Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: M09AX02

Artobend(autologous human chondrocytes in vitro expanded)

Fractures, Cartilage

Marketing Authorisation Holder: TETEC Tissue Engineering Technologies AG

INN: autologous human chondrocytes in vitro expanded

Indication

Repair of cartilage defects of the knee joint.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Artobend — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.